How to Comply with cGMPs

Posted on April 2013 by Cathy Burgess; Appendix by Neil Di Spirito

Instant Access, Purchase and Download Now by Cathy Burgess; Appendix by Neil Di Spirito All pharmaceutical and biologics stakeholders should understand the importance of compliance with and ...read more

Instant Access, Purchase and Download Now by Dale Cooke Food and Drug Administration enforcement action for promotional activities remains vigorous, and digital tactics receive more than their fai...read more

The Drug/Biologics Approval Process: An FDLI Primer

Posted on January 2013 by Brian Malkin and Scot Pittman

Instant Access, Purchase and Download Now by Brian Malkin and Scot Pittman This publication will explain, in practical terms, the approval processes for drugs and biologics. It will ...read more

The Cosmetics Regulatory Process

Posted on January 2013 by Elizabeth H. Anderson and Farah K. Ahmed

Instant Access, Purchase and Download Now by Elizabeth H. Anderson and Farah K. Ahmed The Cosmetics Regulatory Process primer provides a thorough baseline of key legal concepts and issues from...read more

Controlled Substances: FDA and DEA Regulation of Pharmaceuticals

Posted on June 2012 by Lynn W. Mehler, Esq. and David M. Fox, Esq.

Instant Access, Purchase and Download Now by Lynn W. Mehler, Esq. and David M. Fox, Esq. “Controlled Substances: FDA and DEA Regulation of Pharmaceuticals” is a must-have Primer ...read more

The New Reality of Sales Force Behavior and Management

Posted on June 2011 by John Oroho, Kenneth R. Meyer, Lauren E. Handler

About This Monograph Prior to 2012, FDLI published the FDLI Monograph Series, which consisted of six monographs annually. We now publish 4 to 6 Primers each year. Life sciences companies ...read more

Utilizing REMS to Mitigate the Safety Risks of Pharmaceuticals

Posted on November 2010 by Gary H. Slatko, Linda J. Scarazzini, Kathleen M. Sanzo

About This Monograph Prior to 2012, FDLI published the FDLI Monograph Series, which consisted of six monographs annually. We now publish 4 to 6 Primers each year. In 2009, the Food and D...read more

Effective Advocacy in FDA Matters

Posted on October 2010 by James Czaban, Bert Rein

About This Monograph Prior to 2012, FDLI published the FDLI Monograph Series, which consisted of six monographs annually. We now publish 4 to 6 Primers each year. The Food and Drug Admini...read more

The 505(b)(2) New Drug Application Process: The Essential Primer

Posted on June 2010 by Alan Minsk, Lanchi Nguyen, Diana Rusk Cohen

About This Monograph Prior to 2012, FDLI published the FDLI Monograph Series, which consisted of six monographs annually. We now publish 4 to 6 Primers each year. The old saying “ti...read more

Selling Pharmaceuticals to the Federal Government

Posted on June 2010 by Sturm and Pugsley

About This Monograph  Prior to 2012, FDLI published the FDLI Monograph Series, which consisted of six monographs annually. We now publish 4 to 6 Primers each year. Does your com...read more